A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth

BACKGROUND: Human hepatocellular carcinoma (HCC) lacks effective curative therapy and there is an urgent need to develop a novel molecular-targeted therapy for HCC. Selective tyrosine kinase inhibitors have shown promise in treating cancers including HCC. Tyrosine kinases c-Met and Trks are potentia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Luo, Teng, Zhang, Shou-Guo, Zhu, Ling-Fei, Zhang, Fei-Xiang, Li, Wei, Zhao, Ke, Wen, Xiao-Xue, Yu, Miao, Zhan, Yi-Qun, Chen, Hui, Ge, Chang-Hui, Gao, Hui-Ying, Wang, Lin, Yang, Xiao-Ming, Li, Chang-Yan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421704/
https://ncbi.nlm.nih.gov/pubmed/30885237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1104-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados